DYNE THERAPEUTICS INC COM is a security (CUSIP 26818M108) tracked across SEC portfolio filings. 242 institutional managers reported $2.8B on Form 13F as of 2026-06-30; 28 registered fund positions totaling $445.9M via N-PORT as of 2026-05-31.
Showing 15 of 242 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | LONDON, X0 | $247.4M | 13,647,376 |
| VANGUARD GROUP INC | Valley Forge, PA | $219.4M | 11,215,565 |
| BlackRock, Inc. | New York, NY | $212.1M | 11,699,870 |
| Atlas Venture Life Science Advisors, LLC | Cambridge, MA | $165.5M | 9,130,465 |
| FMR LLC | BOSTON, MA | $161.5M | 8,908,980 |
| Orbis Allan Gray Ltd | HamiltoN, D0 | $122.6M | 6,762,231 |
| STATE STREET CORP | BOSTON, MA | $120.6M | 6,653,746 |
| PERCEPTIVE ADVISORS LLC | NEW YORK, NY | $84.6M | 4,668,839 |
| FCPM III SERVICES B.V. | NAARDEN, P7 | $84.2M | 4,644,386 |
| TCG Crossover Management, LLC | PALO ALTO, CA | $83.7M | 4,615,144 |
| Vestal Point Capital, LP | NEW YORK, NY | $72.5M | 4,000,000 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $63.5M | 3,504,114 |
| ARMISTICE CAPITAL, LLC | NEW YORK, NY | $57.6M | 3,175,110 |
| Frazier Life Sciences Management, L.P. | MENLO PARK, CA | $57.2M | 3,153,082 |
| JPMORGAN CHASE & CO | NEW YORK, NY | $55.6M | 3,253,473 |
Showing 15 of 28 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. | T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | $127.1M | 157.53% |
| T. Rowe Price Small-Cap Value Fund, Inc. | T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | $83.9M | 90.94% |
| T. Rowe Price Institutional Small-Cap Stock Fund | T. Rowe Price Equity Funds, Inc. | $69.1M | 159.42% |
| Fidelity Growth Company Fund | Fidelity Mt. Vernon Street Trust | $55.3M | 5.60% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $29.1M | 3.57% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $15.8M | 12.39% |
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $13.9M | 246.97% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $13.2M | 7.55% |
| abrdn Healthcare Investors | abrdn Healthcare Investors | $12.1M | 106.27% |
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $4.6M | 2.10% |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund | T. ROWE PRICE SPECTRUM FUNDS II, INC. | $4.4M | 10.20% |
| U.S. MICRO CAP PORTFOLIO | DFA INVESTMENT DIMENSIONS GROUP INC | $4.1M | 5.52% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $3.7M | 7.75% |
| AZL T Rowe Price Capital Appreciation Fund | Allianz Variable Insurance Products Trust | $1.6M | 18.33% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $1.5M | 0.26% |